Updates & Ideas

Fevertree - Chairman acquires 45,000 shares

March 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Fevertree has often been described as a disruptor for taking on and beating the might of the soft drinks establishment (Coca Cola-owned Schweppes) with its premium tonic water and other mixers. The genesis for Fevertree dates back to 2003 when co-founders Charles Rolls and Tim Warrilow worked together to develop a premium tonic water, a carbonated soft drink in which quinine - used many years ago to treat malaria - is dissolved to give a distinctive bitter flavour. Rolls had previously been the director responsible for resurrecting Plymouth gin into a thriving brand by upping its alcohol content and increasing aromatic oils including juniper, he has pulled off another extraordinary feat with Fevertree indian tonic water. Launched ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Elementis - Disposals boost specialty chemicals firm’s margins

Luceco - Trading ahead of expectations

Fevertree Drinks - Premium tonic water firm eyes $1.2bn US mixer market (March 2019)

Fevertree (July 2017)

Fevertree - Shares break to new highs (March 2017)

Fevertree Drinks - Brokers upgrade again (September 2016)

Fevertree Drinks - Purveyor of premium tonic water enjoys multiple eps upgrades (August 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X